» Articles » PMID: 29973444

[Systemic Lupus Erythematosus with Marked Eosinophilia and Clinical Features Mimicking TAFRO Syndrome]

Overview
Journal Rinsho Ketsueki
Specialty Hematology
Date 2018 Jul 6
PMID 29973444
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A 76-year-old woman was referred to our hospital because of fever, hemorrhagic skin lesion with pruritus, and severe thrombocytopenia. Anemia; marked eosinophilia; and elevated ALP, CRP, and soluble IL-2 receptor levels were observed on admission. Both anti-nuclear antibody and Coombs tests were positive. Computed tomography revealed bilateral pleural effusion, ascites, abdominal lymphadenopathy, and mild hepatosplenomegaly. A thorough examination for the initial differential diagnoses excluded the possibility of myeloid/lymphoid neoplasms with eosinophilia and gene rearrangement, infectious diseases, and eosinophilic granulomatosis with polyangiitis. Remaining possibilities included angioimmunoblastic T-cell lymphoma (AITL) and systemic inflammatory disorders. Although AITL was plausible, there was no histological evidence to support the diagnosis. The patient was then administered prednisolone alone, which led to a lasting resolution of her symptoms. The atypical AITL course raised the suspicion of a misdiagnosis; thus the possibility of an inflammatory disease was reconsidered. TAFRO syndrome was suspected owing to its characteristic clinical features (thrombocytopenia, anasarca, fever and organomegaly). Since a definitive diagnosis required the exclusion of systemic lupus erythematosus (SLE), anti-double-stranded DNA antibody was tested in the initial frozen serum sample. An unexpected positive result led to the final diagnosis of SLE. Here, we report a rare case of SLE lacking typical symptoms and exhibiting various hematological abnormalities, such as eosinophilia.

Citing Articles

International definition of iMCD-TAFRO: future perspectives.

Nishimura Y, Nishimura M, Sato Y J Clin Exp Hematop. 2022; 62(2):73-78.

PMID: 35474036 PMC: 9353848. DOI: 10.3960/jslrt.21037.


Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?.

Nishimura Y, Nishikori A, Sawada H, Czech T, Otsuka Y, Nishimura M J Clin Exp Hematop. 2022; 62(2):99-105.

PMID: 35249898 PMC: 9353850. DOI: 10.3960/jslrt.21038.


Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease.

Nishimura Y, Fajgenbaum D, Pierson S, Iwaki N, Nishikori A, Kawano M Am J Hematol. 2021; 96(10):1241-1252.

PMID: 34265103 PMC: 9642098. DOI: 10.1002/ajh.26292.


Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor: A case report.

Kadoba K, Waki D, Nishimura K, Mukoyama H, Saito R, Murabe H Medicine (Baltimore). 2020; 99(42):e22793.

PMID: 33080751 PMC: 7571883. DOI: 10.1097/MD.0000000000022793.